Examination of the effect of food containing lactic acid bacteria WB21 on oral Candida species

Examination of the effect of food containing lactic acid bacteria Lactobaciilus salivarius WB21 on oral Candida species - Effect of tablets containing Lactobacillus salivarius WB21 in oral Candida species

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057538

Enrollment

Registered

2025-06-01

Start date

2025-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral candidiasis

Interventions

Study participants were asked to take &quot

Avantbise Oral Tablets&quot

(Wakamoto Pharmaceutical Co., Ltd.), a food containing Lactobacillus salivarius WB21, three times a day for two consecutive weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Residents of a certain nursing home in Fukuoka who have been found to have the presence of Candida in their mouths

Exclusion criteria

Exclusion criteria: Those who are already using food containing WB21 / Those taking antibiotics / Those with a history of milk allergy or food allergy to food ingredients / Those who the researcher judges to be inappropriate as study participants

Design outcomes

Primary

Measure	Time frame
the number of Candida species in the mouth	—

Countries

Japan

Contacts

Public ContactNao Taniguchi

Fukuoka Dental College Department of Preventive and Public Health Dentistry

naojsz@fdcnet.ac.jp81-92-801-0616

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026